Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Physiol Gastrointest Liver Physiol ; 315(1): G36-G42, 2018 07 01.
Article in English | MEDLINE | ID: mdl-29517927

ABSTRACT

The H+,K+-ATPase was identified as the primary proton secretory pathway in the gastric parietal cell and is the pharmacological target of agents suppressing acid secretion. Recently, we identified a second acid secretory protein expressed in the parietal cell, the vacuolar H+-ATPase (V-type ATPase). The aim of the present study was to further characterize H+-ATPase activation by modulations in extracellular calcium via the calcium sensing receptor (CaSR). Isolated gastric glands were loaded with the pH indicator dye BCECF-AM [2',7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein acetoxymethyl ester] to measure intracellular pH. Experiments were conducted in the absence of sodium and potassium to monitor H+-ATPase-specific transport activity. CaSR was activated with the calcimimetic R568 (400 nM) and/or by modulations in extracellular Ca2+. Elevation in calcium concentrations increased proton extrusion from the gastric parietal cell. Allosteric modification of the CaSR via R568 and calcium increased vacuolar H+-ATPase activity significantly (ΔpH/minlowCa2+(0.1mM) = 0.001 ± 0.001, ΔpH/minnormalCa2+(1.0mM) = 0.033 ± 0.004, ΔpH/minhighCa2+(5.0mM) = 0.051 ± 0.005). Carbachol significantly suppressed calcium-induced gastric acid secretion via the H+-ATPase under sodium- and potassium-free conditions. We conclude that the V-type H+-ATPase is tightly linked to CaSR activation. We observed that proton pump inhibitor (PPI) exposure does not modulate H+-ATPase activity. This elevated blood calcium activation of the H+-ATPase could provide an explanation for recurrent reflux symptoms while taking a PPI therapy. NEW & NOTEWORTHY This study emphasizes the role of the H+-ATPase in acid secretion. We further demonstrate the modification of this proton excretion pathway by extracellular calcium and the activation of the calcium sensing receptor CaSR. The novelty of this paper is based on the modulation of the H+-ATPase via both extracellular Ca (activation) and the classical secretagogues histamine and carbachol (inactivation). Both activation and inactivation of this proton pump are independent of PPI modulation.


Subject(s)
Calcium , Enzyme Activation , H(+)-K(+)-Exchanging ATPase/metabolism , Parietal Cells, Gastric , Proton Pump Inhibitors/pharmacology , Proton Pumps , Receptors, Calcium-Sensing/metabolism , Animals , Calcium/blood , Calcium/metabolism , Carbachol/pharmacology , Cholinergic Agonists/pharmacology , Enzyme Activation/drug effects , Enzyme Activation/physiology , Gastric Acid/metabolism , Histamine/metabolism , Ion Transport/drug effects , Ion Transport/physiology , Parietal Cells, Gastric/drug effects , Parietal Cells, Gastric/physiology , Proton Pumps/drug effects , Proton Pumps/metabolism , Rats , Rats, Sprague-Dawley , Secretory Pathway/drug effects , Secretory Pathway/physiology
2.
J Gastrointest Surg ; 20(2): 313-21, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26487331

ABSTRACT

INTRODUCTION: The small intestine is one of the most ischemia-sensitive organs used in transplantation. To better preserve the intestinal graft viability and decrease ischemia-reperfusion injury, a device for extracorporeal perfusion was developed. We present the results for the first series of perfused human intestine with an intestinal perfusion unit (IPU). METHODS: Five human intestines were procured for the protocol. (1) An experimental segment was perfused by the IPU delivering cold preservation solution to the vascular and luminal side continually at 4 ºC for 8 h. (2) Control (jejunum and ileum) segments were preserved in static cold preservation. Tissue samples were obtained for histopathologic grading according to the Park/Chiu scoring system (0 = normal, 8 = transmural infarction). RESULTS: Jejunal experimental segments scored 2.2 with the Park/Chiu system compared to the control segments, which averaged 3.2. Overall scoring for ileum experimental and control segments was equal with 1.6. CONCLUSION: This data presents proof of concept that extracorporeal intestinal perfusion is feasible. The evidence shows that the IPU can preserve the viability of human intestine, and histopathologic evaluation of perfused intestine is favorable. Our early results can eventually lead to expanding the possibilities of intestinal preservation.


Subject(s)
Extracorporeal Circulation/instrumentation , Intestine, Small/pathology , Ischemia/prevention & control , Organ Preservation/instrumentation , Specimen Handling , Humans , Hypothermia, Induced , Intestine, Small/blood supply , Intestine, Small/transplantation , Organ Preservation/methods , Reperfusion Injury/pathology , Reperfusion Injury/prevention & control , Tissue Culture Techniques
3.
J Surg Res ; 197(2): 225-30, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25976849

ABSTRACT

BACKGROUND: Small intestine ischemia can be seen in various conditions such as intestinal transplantation. To further understand the pathologic disruption in ischemia-reperfusion injury, we have developed a method to measure fluid changes in the intestinal lumen of rats. METHODS: Two 10-cm rat intestine segments were procured, connected to the terminal apertures of a perfusion device, and continuously infused with 3 mL of HEPES solution (control solution) containing 50 µM of fluorescein isothiocyanate (FITC)-inulin. The perfusion device consists of concentric chambers that contain the perfused bowel segments, which are maintained at 37°C via H2O bath. The individual chamber has four apertures as follows: two fill and/or drain the surrounding HEPES solution on the blood side of the tissue. The others provide flow of HEPES solution containing FITC-inulin through the lumens. The experimental intestine was infused with the same solution with 100 µM of Forskolin. A pump continuously circulated solutions at 6 mL/min. Samples were collected at 15-min intervals until 150 min and were measured by the nanoflourospectrometer. RESULTS: A mean of 6-µM decrease in the FITC-inulin concentration in the Forskolin-treated experimental intestine was observed in comparison with that in the control intestine. The FITC-inulin count dilution in the experimental intestine is a result of an increase of fluid secretion produced by the effect of Forskolin, with P values <0.0001. CONCLUSIONS: We demonstrate that it is possible to measure luminal fluid changes over time using our new modified perfusion system along with FITC-inulin to allow real-time determinations of fluid and/or electrolyte movement along the small intestine.


Subject(s)
Fluorescein-5-isothiocyanate/analogs & derivatives , Fluorescent Dyes , Intestinal Secretions/physiology , Intestine, Small/physiopathology , Inulin/analogs & derivatives , Reperfusion Injury/physiopathology , Animals , Male , Perfusion , Random Allocation , Rats , Rats, Sprague-Dawley , Spectrometry, Fluorescence
4.
Pflugers Arch ; 467(7): 1457-1468, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25127675

ABSTRACT

Potassium channels comprise the apical leak pathway supplying extracellular K(+) for exchange with protons by the gastric H(+), K(+)-ATPase and provide potential therapeutic targets for inhibiting gastric acid secretion. The Kir1.1 (ROMK) potassium channel mediates the high capacity K(+) recycling necessary for NaCl reabsorption in the thick ascending limb of the kidney, and this channel exhibits functional and regulatory characteristic well suited for K(+) recycling by gastric parietal cells. We report here that Kir1.1 channels are required for gastric acid secretion and that this channel participates with Kv7.1 (KCNQ1/KvLQT1) in the potassium recycling process. We show that Kir1.1 colocalizes with the ß-subunit of H(+), K(+)-ATPase in gastric parietal cells of Kir1.1 wild-type mice. In Kir1.1-deficient mice, gastric mucosal morphology, as well as parietal cell number, proliferation index, and ultrastructure were normal but secretagogue-stimulated gastric acid secretion in whole stomach and perfused gastric glands was absent. Luminal application of potassium-restored acid secretion in perfused gastric glands from Kir1.1-deficient as well as barium-blocked wild-type mice. In wild-type mice, both luminal Tertiapin-Q, an inhibitor of Kir1.1, as well as XE991, an inhibitor of Kv7.1, reduced proton secretion. We propose that Kir1.1 and Kv7.1 channels collaborate in potassium and current recycling across the apical pole of parietal cells.


Subject(s)
Gastric Acid/metabolism , Gastric Mucosa/metabolism , KCNQ1 Potassium Channel/metabolism , Potassium Channels, Inwardly Rectifying/metabolism , Animals , KCNQ1 Potassium Channel/genetics , Mice , Mice, Inbred C57BL , Potassium Channels, Inwardly Rectifying/genetics , Stomach/cytology , Xenopus
5.
Am J Physiol Cell Physiol ; 307(3): C221-31, 2014 Aug 01.
Article in English | MEDLINE | ID: mdl-24871857

ABSTRACT

The calcium-sensing receptor (CaSR) has played an important role as a target in the treatment of a variety of disease states over the past 20 plus years. In this review, we give an overview of the receptor at the cellular level and then provide details as to how this receptor has been targeted to modulate cellular ion transport mechanisms. As a member of the G protein-coupled receptor (GPCR) family, it has a high degree of homology with a variety of other members in this class, which could explain why this receptor has been identified in so many different tissues throughout the body. This diversity of locations sets it apart from other members of the family and may explain how the receptor interacts with so many different organ systems in the body to modulate the physiology and pathophysiology. The receptor is unique in that it has two large exofacial lobes that sit in the extracellular environment and sense changes in a wide variety of environmental cues including salinity, pH, amino acid concentration, and polyamines to name just a few. It is for this reason that there has been a great deal of research associated with normal receptor physiology over the past 20 years. With the ongoing research, in more recent years a focus on the pathophysiology has emerged and the effects of receptor mutations on cellular and organ physiology have been identified. We hope that this review will enhance and update the knowledge about the importance of this receptor and stimulate future potential investigations focused around this receptor in cellular, organ, and systemic physiology and pathophysiology.


Subject(s)
Calcium Signaling/genetics , Calcium/metabolism , Receptors, Calcium-Sensing/genetics , Animals , Gastric Mucosa/metabolism , Humans , Intestinal Mucosa/metabolism , Intestines/physiology , Kidney/metabolism , Kidney/physiology , Mice , Mutation , Rats , Receptors, Calcium-Sensing/physiology , Renal Insufficiency, Chronic , Skin/metabolism , Stomach/physiology
6.
J Pediatr Surg ; 47(5): 867-73, 2012 May.
Article in English | MEDLINE | ID: mdl-22595563

ABSTRACT

PURPOSE: Herein, we describe a new surgical approach for chest wall reconstruction using a native supporting rib and Surgisis. METHODS: A retrospective review of 3 cases from 2 tertiary pediatric health care centers presenting with chest wall defects in the neonatal period was performed. Perioperative data were collected. RESULTS: Two chest wall deformities were diagnosed at birth (Poland syndrome and cleft sternum). One patient was diagnosed prenatally with a mediastinal mass. The first infant had absent ribs 2 through 9. He underwent chest wall reconstruction at 4 weeks of life because of difficulty weaning from ventilation related to paradoxical breathing. The hamartoma of the second asymptomatic patient was removed at 6 weeks. The third patient's V-shaped sternal defect encompassed through the upper two thirds of the sternum and was repaired at 6 months of age with intraoperative transesophageal echocardiogram monitoring. In all cases, Surgisis (collagen matrix) was used as an onlay patch. In 2 cases, a swinging rib acted supportive. Neither patient had intraoperative complications. CONCLUSION: Surgisis is useful in pediatric chest wall reconstruction, particularly in combination with swinging ribs. The capacity for adaptation to the child's growth of this approach is crucial. Short-term safety is shown, but long-term assessment is required.


Subject(s)
Biocompatible Materials , Collagen , Orthopedic Procedures/methods , Ribs/surgery , Thoracic Wall/surgery , Tissue Scaffolds , Female , Hamartoma/surgery , Humans , Infant , Infant, Newborn , Male , Mediastinal Diseases/surgery , Orthopedic Procedures/instrumentation , Poland Syndrome/surgery , Retrospective Studies , Sternum/abnormalities , Sternum/surgery , Thoracic Wall/abnormalities , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...